Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 3
2018 2
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
CD74 is a novel transcription regulator.
Gil-Yarom N, Radomir L, Sever L, Kramer MP, Lewinsky H, Bornstein C, Blecher-Gonen R, Barnett-Itzhaki Z, Mirkin V, Friedlander G, Shvidel L, Herishanu Y, Lolis EJ, Becker-Herman S, Amit I, Shachar I. Gil-Yarom N, et al. Among authors: mirkin v. Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):562-567. doi: 10.1073/pnas.1612195114. Epub 2016 Dec 28. Proc Natl Acad Sci U S A. 2017. PMID: 28031488 Free PMC article.
CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia.
Lewinsky H, Barak AF, Huber V, Kramer MP, Radomir L, Sever L, Orr I, Mirkin V, Dezorella N, Shapiro M, Cohen Y, Shvidel L, Seiffert M, Herishanu Y, Becker-Herman S, Shachar I. Lewinsky H, et al. Among authors: mirkin v. J Clin Invest. 2018 Dec 3;128(12):5465-5478. doi: 10.1172/JCI96610. Epub 2018 Nov 5. J Clin Invest. 2018. PMID: 30277471 Free PMC article.
A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach.
Haran M, Mirkin V, Braester A, Harpaz N, Shevetz O, Shtreiter M, Greenberg S, Mordich O, Amram O, Binsky-Ehrenreich I, Marom A, Shachar I, Herishanu Y, Ruchlemer R, Berrebi A, Valinsky L, Shtalrid M, Shvidel L. Haran M, et al. Among authors: mirkin v. Br J Haematol. 2018 Jul;182(1):125-128. doi: 10.1111/bjh.14726. Epub 2017 May 3. Br J Haematol. 2018. PMID: 28466956 Free article. Clinical Trial. No abstract available.
Peripheral Blood Cell Mitochondrial Dysfunction in Myelodysplastic Syndrome Can Be Improved by a Combination of Coenzyme Q10 and Carnitine.
Filanovsky K, Haran M, Mirkin V, Braester A, Shevetz O, Stanevsky A, Sigler E, Votinov E, Zaltsman-Amir Y, Berrebi A, Gross A, Shvidel L. Filanovsky K, et al. Among authors: mirkin v. Mediterr J Hematol Infect Dis. 2020 Nov 1;12(1):e2020072. doi: 10.4084/MJHID.2020.072. eCollection 2020. Mediterr J Hematol Infect Dis. 2020. PMID: 33194146 Free PMC article.